Soft tissue sarcoma

This Childhood Cancer Awareness Month, we caught up with families who have been affected by children’s and young people’s cancers to find out how COVID-19 has impacted them and their loved ones.

How our partnership with Children with Cancer UK is helping to transform our understanding of children’s and young people’s cancers.

A study led by The Institute of Cancer Research, part-funded by Cancer Research UK, finds genetic changes in children with rare cancer could help tailor treatment.

The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers.

A Cancer Research UK funded trial will offer new treatments for children and adults with a form of muscle cancer called rhabdomyosarcoma that has returned or does not respond to current treatments.

Birmingham will be at the forefront of developments in childhood cancer research thanks to the launch of a new team which will co-ordinate groundbreaking clinical trials across the UK.

Childhood cancer survivors who are most at risk of developing a second cancer are more likely to smoke than other childhood cancer survivors – reveals a Cancer Research UK study published in the Journal of the National Cancer Institute* today (Tuesday).

Substances present in the environment may trigger certain rare kinds of childhood cancer, according to a new study1 by Cancer Research UK scientists in Manchester.